David Morgenthaler founded the firm in 1968 after a successful career as an operating executive. After his venture-backed business was sold to an international company, Dave decided that there was a tremendous opportunity for private venture capital investing. He then built a small Cleveland-based venture capital firm with a goal of investing in a variety of private technology companies nationally. He also took a leadership role in establishing the legitimacy and potential of the nascent venture capital industry.
Among his many contributions to the emerging industry, Dave was president of the National Venture Capital Association (NVCA) when the capital gains tax reduction was enacted in 1978, and played a leading role in testifying before Congress for the new legislation. He was also instrumental in helping pass the ERISA legislation of 1979, allowing for pension funds to invest in private equity for the first time. Dave was given the first National Venture Capital Lifetime Achievement Award in 1998 in recognition for his contributions.
Morgenthaler began raising institutional funds in the 1980s, and has since grown to become a uniquely national firm. Today, the life science venture capital practice is based in Palo Alto, CA, with offices in Boston, MA and Boulder, CO.
We have worked with entrepreneurs in approximately 300 companies since the firm’s founding. We strive to be the entrepreneur’s most trusted partner.